BRAF and neoplasm: When the entire cohort was stratified according to the BRAF status (BRAFWT versus BRAFV600E), we observed that samples presenting BRAFV600E also overexpressed BRAF in the tumor microenvironment—odds ratio (OR) = 4.3; 95% confidence intervals (95% CI) = 1.301–11.61.